Rare Revolution Magazine, an online publication dedicated to promoting awareness of rare diseases, published an article "Cystinuria: In the Spotlight" in its Spring 2018 issue containing an interview with NYU Langone collaborator Dr. David Goldfarb and spotlighting the NYU-Rutgers collaboration that is developing small molecule drugs that mitigate cystine crystal growth and the formtaion of stones.